Steve Schonfeld Schonfeld Strategic Advisors
Steve Schonfeld is the founder of Schonfeld Strategic Advisors, a multi-manager investment firm with roots in proprietary trading. Schonfeld allocates capital across quantitative and discretionary strategies with an emphasis on risk controls and diversification of return streams. The firm is a major name in the multi-strategy hedge fund landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arthur J. Gallagher & Co
AJG
|
+$110M |
| 2 |
Willis Towers Watson
WTW
|
+$70.4M |
| 3 |
Gen Digital
GEN
|
+$63.3M |
| 4 |
Goldman Sachs
GS
|
+$53.6M |
| 5 |
Bio-Rad Laboratories Class A
BIO
|
+$51.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$110M |
| 2 |
Meta Platforms (Facebook)
META
|
+$72.2M |
| 3 |
Global Payments
GPN
|
+$43.3M |
| 4 |
Cardinal Health
CAH
|
+$41.2M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$40.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 28.08% |
| 2 | Technology | 14.83% |
| 3 | Healthcare | 8.61% |
| 4 | Consumer Discretionary | 7.67% |
| 5 | Industrials | 7.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HR
701
DELISTED
Healthcare Realty Trust Incorporated
HR
| $2.06M | 0.02% |
69,300
-188,344
| -73% | -$5.77M |
|
|
TCRR
702
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $2.06M | 0.02% |
+241,761
| New | +$3.42M |
|
703
NXP Semiconductors
NXPI
$56B
| $2.06M | 0.02% |
+10,500
| New | +$2.18M |
|
704
CALL
American Airlines Group
AAL
$9.06B
| $2.05M | 0.02% |
+100,000
| New | +$2.03M |
|
|
EQRX
705
DELISTED
EQRx, Inc. Common Stock
EQRX
| $2.05M | 0.02% |
+206,643
| New | +$2.07M |
|
|
VISN
706
Vistance Networks Inc
VISN
$2.5B
| $2.04M | 0.02% |
150,455
-1,263,269
| -89% | -$21.7M |
|
|
TGI
707
DELISTED
Triumph Group
TGI
| $2.04M | 0.02% |
109,600
+40,000
| +57% | +$745K |
|
|
SVOK
708
DELISTED
Seven Oaks Acquisition Corp. Class A Common Stock
SVOK
| $2.04M | 0.02% |
205,227
+62,506
| +44% | +$618K |
|
|
BPMC
709
DELISTED
Blueprint Medicines
BPMC
| $2.04M | 0.02% |
+19,818
| New | +$1.85M |
|
710
Live Nation Entertainment
LYV
$42.7B
| $2.04M | 0.02% |
+22,333
| New | +$1.88M |
|
711
Citi Trends
CTRN
$620M
| $2.03M | 0.02% |
27,860
+1,550
| +6% | +$124K |
|
712
Telkom Indonesia
TLK
$14.8B
| $2.01M | 0.02% |
+79,007
| New | +$1.82M |
|
713
Chipotle Mexican Grill
CMG
$47.9B
| $2M | 0.02% |
+55,000
| New | +$2M |
|
714
DoorDash
DASH
$99.4B
| $2M | 0.02% |
9,700
-65,400
| -87% | -$12.5M |
|
715
EPAM Systems
EPAM
$5.74B
| $2M | 0.02% |
3,500
+2,535
| +263% | +$1.49M |
|
716
Clearway Energy Class C
CWEN
$6.64B
| $2M | 0.02% |
65,900
+43,400
| +193% | +$1.29M |
|
|
AGNT
717
CALL
AGNT Inc
AGNT
$752M
| $1.99M | 0.02% |
50,000
+35,000
| +233% | +$1.5M |
|
|
MREO
718
Mereo BioPharma
MREO
$46.6M
| $1.99M | 0.02% |
820,793
-504,260
| -38% | -$1.34M |
|
719
Keurig Dr Pepper
KDP
$44.1B
| $1.98M | 0.02% |
58,000
-14,262
| -20% | -$499K |
|
720
TELA Bio
TELA
$29.3M
| $1.97M | 0.02% |
144,353
+7,400
| +5% | +$103K |
|
721
Cooper Companies
COO
$14.9B
| $1.97M | 0.02% |
19,080
-73,444
| -79% | -$7.84M |
|
|
SILK
722
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $1.97M | 0.02% |
+35,794
| New | +$1.87M |
|
723
Levi Strauss
LEVI
$8.33B
| $1.96M | 0.02% |
80,000
+54,600
| +215% | +$1.47M |
|
724
WEX
WEX
$6.92B
| $1.96M | 0.02% |
11,128
-35,402
| -76% | -$6.45M |
|
725
Zentalis Pharmaceuticals
ZNTL
$359M
| $1.95M | 0.02% |
29,287
+8,451
| +41% | +$488K |
|
Similar funds
Steve Schonfeld's Q3 2021 Portfolio in Review
As of Q3 2021, Steve Schonfeld held 2,698 positions worth $9.68B, up 3% from $9.4B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Steve Schonfeld deployed $368M of net new capital in Q3 2021, opening 807 new positions and adding to 606 existing holdings. Its largest new stake was Arthur J. Gallagher & Co: 770,871 shares worth $115M.
By sector, the portfolio is most concentrated in Financials at 28% of assets, up from 26% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Amazon, an estimated $110M trimmed.
- Steve Schonfeld's largest Q3 2021 buy was Arthur J. Gallagher & Co: 770,871 shares worth $115M.
- Steve Schonfeld added most to Willis Towers Watson in Q3 2021, an estimated $70.4M increase.
- Steve Schonfeld's biggest Q3 2021 reduction was Amazon, cutting an estimated $110M.
- Steve Schonfeld fully exited Cardinal Health in Q3 2021, selling an estimated $41.2M.
- Steve Schonfeld's ten largest holdings make up 11% of its $9.68B portfolio in Q3 2021.
- Steve Schonfeld opened 807 new positions and closed 588 in Q3 2021.
- Steve Schonfeld's portfolio value rose 3% quarter-over-quarter to $9.68B.
Based on Schonfeld Strategic Advisors's 13F filing for Q3 2021, filed 16 Nov 2021.